摘要
目的探讨血清淀粉酶A蛋白(SAA)、中性粒细胞表面抗原CD64在新生儿败血症诊断及疗效评价中的价值。方法 2011年5月至2012年5月住院并疑为感染的80例新生儿,分为败血症组35例,非败血症感染组45例;另设对照组20例。检测各组入院时,以及败血症组在治疗1周后的SAA、CD64水平,各组间进行比较,并分析SAA、CD64诊断败血症的敏感性和特异性。结果败血症组和非败血症感染组CD64、SAA均明显高于对照组,差异有统计学意义(P<0.01);败血症组CD64水平高于非败血症感染组,差异亦有统计学意义(P<0.01)。败血症组经抗感染治疗1周后CD64及SAA水平均较治疗前下降,差异有统计学意义(P均<0.01)。以CD64≥2 943个荧光抗体分子/细胞、SAA≥5.3 mg/L、CRP≥8 mg/L为阳性标准,CD64诊断败血症的敏感性和特异性分别为91.43%、90.00%均较SAA及CRP高。结论中性粒细胞表面抗原CD64是早期诊断新生儿败血症的灵敏指标之一。
Objectives To investigate the value of serum amyloid A (SAA) and neutrophils cell surface antigen 64 (CD64) in the early diagnosis of neonatal septic'emia. Methods Eighty neonates in a neonatal ward between May 2011 and May 2012 were divided into sepsis group (n=35) and non-septicemic infection group (n=45). Twenty hospitalized neonates with non- infectious diseases were enrolled as controls (n=20). SAA and CD64 were measured upon admission and during the recovery period (1 week post-treatment) and their sensitivity and specificity were analysed. Results The expressions of CD64 and SAA were significantly higher in sepsis group and non-septicemic infection group than those in control group (P〈0.01). The expres- sion of CD64 was significantly higher in sepsis group than that in non-septicemic infection group (P〈0.01). The expressions of CD64 and SAA were significantly decreased in sepsis group 1 week after treatment as compared to before treatment (P〈0.01). When the cutoff values for CD64, SAA and CRP were 2943 molecules/cell, 5.3 mg/L and 8 mg/L, CD64 had higher diagnos- tic sensitivity and specificity for sepsis (91.43% and 90.00%) than SAA and CRE Conclusions CD64 is a sensitive indicator for the early diagnosis of neonatal septicemia.
出处
《临床儿科杂志》
CAS
CSCD
北大核心
2013年第6期526-529,共4页
Journal of Clinical Pediatrics
基金
温州市科技计划项目(NO.Y20100248)